GLP-1 Labs Before You Start: The Checklist To Get Safer, Smoother Results In 2026











If you're about to start a GLP-1 medication like semaglutide or tirzepatide, it's tempting to focus on one thing: the prescription. But the people who tend to do best long-term usually start with something less exciting and far more useful, a clean baseline.
A "GLP-1 labs before starting checklist" isn't about over-testing. It's about safety (making sure your body can tolerate treatment), context (knowing what's already going on), and problem-solving later (so if nausea, constipation, fatigue, or abnormal labs show up, you and your clinician aren't guessing).
In 2026, most clinicians consider labs from the past 6 months a reasonable baseline for starting, but what you include in that panel should reflect your personal risk factors, symptoms, and goals. Here's a practical checklist you can bring to your appointment.
Why Baseline Labs Matter Before Semaglutide Or Tirzepatide
Baseline labs do three jobs before you ever take your first dose.
First, they screen for issues that change how "safe" GLP-1 therapy is for you right now. GLP-1 medications can reduce appetite and slow gastric emptying (how fast food moves out of your stomach). That's often helpful, but it can also worsen dehydration, constipation, reflux, or nausea in people who are already vulnerable. If your kidney function is borderline, or if your electrolytes are off before you start, side effects can hit harder.
Second, baseline labs give you a reference point. If you're 8 weeks in and your creatinine has climbed, your sodium is low, or your liver enzymes are elevated, you need to know whether that change is new, or whether it was present before the medication.
Third, they help you measure progress in a way that's not only the scale. Many people start GLP-1s for weight loss, but your cardiometabolic risk (blood sugar, insulin resistance, triglycerides, liver fat risk) is often the bigger story. Labs make that story visible.
Who Should Be Extra Thorough (Perimenopause, Menopause, IBS, Gallbladder History)
You don't need an "everything panel." But you should be more thorough if any of the following applies:
Perimenopause or menopause: Weight gain, sleep disruption, and shifting body composition can overlap with thyroid dysfunction, iron deficiency (especially if bleeding is heavy), and nutrient gaps. Also, appetite suppression can make protein and micronutrient intake slide without you noticing.
IBS or sensitive digestion: GLP-1 therapy can aggravate constipation, bloating, reflux, or food intolerance patterns. If you already live with IBS, it's smart to separate "baseline GI reality" from "medication side effects," and to screen for a few common mimics when indicated.
Gallbladder history or prior gallstones: Rapid weight loss is a known risk factor for gallstones, and gallbladder symptoms can be mistaken for "normal GLP-1 nausea." If you've had biliary issues before, you want a clearer starting point and a plan.
History of dehydration, kidney stones, or chronic kidney disease: You're not disqualified automatically, but you do want a tighter safety net, because reduced intake, vomiting, or diarrhea can affect kidney perfusion (blood flow to the kidneys) and electrolytes more quickly.
The Core Pre-Start Lab Panel To Request
If you're building a GLP-1 labs before starting checklist, this is the core panel most people benefit from. Think of it as your "metabolic and safety dashboard."
Metabolic Basics: A1C, Fasting Glucose, Fasting Insulin (If Appropriate)
Hemoglobin A1C reflects your average blood sugar over about 3 months. Fasting glucose is your blood sugar at one point in time.
Fasting insulin can be useful when your clinician is evaluating insulin resistance (especially if A1C is normal but weight, triglycerides, or abdominal fat suggest metabolic dysfunction). It's not required for everyone, but it can help clarify your baseline.
Why it matters on GLP-1s: These medications can significantly improve glycemic control. If you start with an accurate baseline, you can see how much of your progress is "weight-related" versus "direct metabolic effect."
Kidney And Electrolytes: CMP/BMP (Creatinine, eGFR, Sodium, Potassium)
A BMP (basic metabolic panel) or CMP (comprehensive metabolic panel) typically includes creatinine and electrolytes. Creatinine is used to estimate eGFR, a measure of kidney filtration.
Why it matters on GLP-1s: If nausea reduces your fluid intake, or if vomiting/diarrhea occurs, sodium and potassium can shift and kidney function can look worse. Baseline values make it easier to recognize dehydration-related changes early.
Liver And Biliary Signals: AST/ALT, Alk Phos, Bilirubin
These are usually included in a CMP.
AST and ALT are liver enzymes that can rise with fatty liver disease, medication effects, alcohol use, or other inflammation.
Alkaline phosphatase (Alk Phos) and bilirubin are particularly helpful when thinking about bile flow and gallbladder/biliary tract issues.
Why it matters on GLP-1s: Weight loss often improves fatty liver markers over time, but right after starting, side effects (dehydration) or unrelated gallbladder problems can cloud the picture. A baseline helps you interpret changes with more confidence.
Lipids And Cardiometabolic Risk: Fasting Lipid Panel
A fasting lipid panel usually includes total cholesterol, LDL-C, HDL-C, and triglycerides.
Why it matters on GLP-1s: Triglycerides often improve with reduced insulin resistance and weight loss. Tracking lipids also keeps the focus on cardiovascular risk reduction, not just pounds lost.
Thyroid Screening: TSH (± Free T4 If Indicated)
TSH is the standard screening test for thyroid function. Free T4 is often added if TSH is abnormal or if symptoms strongly suggest thyroid dysfunction.
Why it matters on GLP-1s: Fatigue, constipation, hair shedding, and weight changes can be thyroid-related, GLP-1-related, nutrition-related, or a mix. Knowing your baseline reduces the chance that everything gets blamed on the medication.
CBC And Iron Basics: CBC, Ferritin (When Fatigue Or Heavy Bleeding Is Present)
A CBC (complete blood count) screens for anemia and other blood cell abnormalities.
Ferritin reflects iron stores and can be especially relevant if you have fatigue, heavy periods, postpartum history, or perimenopause-related bleeding changes.
Why it matters on GLP-1s: If your appetite drops, your iron intake can quietly drop too. Also, fatigue on GLP-1s is common: you want to make sure you're not missing an easy-to-treat contributor like iron deficiency.
A simple way to bring this to your clinician is to say: "I'd like baseline metabolic, kidney/electrolyte, liver/biliary, lipids, and thyroid labs before I start, so we have a reference point within the past 6 months."
Add-On Labs Based On Your Risks, Goals, And Symptoms
The core panel is a strong start. Add-ons are where your history matters.
Pancreas Risk: Lipase/Amylase (When Prior Pancreatitis Or Red-Flag Symptoms)
Routine lipase/amylase screening isn't necessary for everyone. But if you have a history of pancreatitis, significant alcohol use disorder, very high triglycerides, or you develop red-flag symptoms (severe, persistent upper abdominal pain, pain radiating to the back, vomiting that won't stop), your clinician may check lipase (and sometimes amylase).
Important nuance: Mild, nonspecific abdominal discomfort is common early on. Pancreatitis is typically a different level of pain and illness. This is exactly why baseline context and symptom education matters.
Gallbladder Risk And Rapid Weight Loss Planning
There isn't one perfect "gallbladder lab." Gallbladder issues often show up as a pattern: right upper abdominal pain (especially after fatty meals), nausea, and sometimes elevated bilirubin or Alk Phos if bile flow is affected.
If you have a known gallstone history, prior biliary colic, or you're anticipating rapid weight loss, ask your clinician how they prefer to monitor risk. Sometimes the best "test" is a symptom plan plus timely imaging if symptoms appear.
Nutrition Status For Appetite Suppression: B12, Folate, Vitamin D, Magnesium
With GLP-1 appetite suppression, the issue isn't only calories, it's micronutrient density. You can unintentionally shift into a pattern where you're eating less overall and also eating fewer nutrient-rich foods (especially protein, leafy greens, legumes, and fortified foods).
Common add-ons to consider:
B12 and folate: Low levels can contribute to fatigue, neuropathy symptoms (tingling), and anemia patterns.
Vitamin D: Low vitamin D is common and may affect mood, muscle function, and bone health. It's not "a GLP-1 deficiency," but reduced intake plus low baseline status is a common combination.
Magnesium: Not always measured accurately in standard serum tests, but it can be helpful in certain situations (constipation, muscle cramps, low intake patterns), depending on your clinician's approach.
Gut Symptoms And IBS Overlap: Celiac Screen, CRP, Stool Testing (When Indicated)
If you already have IBS-like symptoms, it's worth asking a pointed question: "Are we confident this is IBS, or should we rule out something else before I start a medication that can change gut motility?"
Celiac screening: Often a tissue transglutaminase IgA (tTG-IgA) with total IgA, especially if you have chronic bloating/diarrhea, iron deficiency, or a family history.
CRP (C-reactive protein): A general inflammation marker. It doesn't diagnose IBS, but it can help your clinician decide whether further evaluation is needed if symptoms are concerning.
Stool testing: Not routine. But if you have alarm features (blood in stool, unexplained weight loss outside of GLP-1 effects, nighttime diarrhea, persistent fevers) or a travel/infectious story, your clinician may order targeted stool studies.
Reproductive And Hormone Considerations (Perimenopause/Menopause, PCOS)
If you're in perimenopause or menopause, your GLP-1 plan often works best when it's coordinated with a broader metabolic and hormone conversation.
Depending on your symptoms and history, your clinician may consider labs such as:
Pregnancy testing when relevant (even in perimenopause, pregnancy is still possible until menopause is confirmed).
PCOS-related metabolic evaluation (if you have irregular cycles, acne, hair growth changes, or long-standing insulin resistance): your clinician may look at androgens and other markers based on your presentation.
Thyroid expansion beyond TSH if symptoms or history warrant it.
The goal isn't to "chase labs." It's to avoid missing common, treatable factors that can masquerade as GLP-1 side effects, fatigue, constipation, hair shedding, mood shifts, and stalled progress.
Medication Safety And Eligibility Checks To Do Alongside Labs
Labs are only half of a good pre-start checklist. The other half is a structured review of eligibility, safety, and medication interactions.
Contraindications And Family History To Review (Including Thyroid Cancer Syndromes)
GLP-1 receptor agonists have contraindications and precautions that depend on your personal and family history.
Your clinician will typically review:
Personal or family history of medullary thyroid carcinoma (MTC) and multiple endocrine neoplasia type 2 (MEN2). This is a key screening point because of thyroid C-cell tumor findings in rodent studies and the associated labeling warnings.
History of pancreatitis, gallbladder disease, severe GI disease, or prior severe reactions.
Current kidney disease or situations where dehydration risk is high.
Bring your family history as clearly as you can: "my aunt had thyroid cancer" is different from "my father had medullary thyroid cancer." If you don't know the type, say that, your clinician can help figure out whether it matters.
Pregnancy, Fertility, And Contraception Planning
If pregnancy is possible for you, this needs to be discussed before starting. Weight loss medications and GLP-1 agents are generally not used during pregnancy, and planning matters.
Also important: as metabolic health improves and weight decreases, fertility can increase (especially in people with PCOS). So even if pregnancy hasn't been likely in the past, contraception planning may suddenly become relevant.
Medication Reconciliation: Diabetes Drugs, Blood Pressure Meds, GERD Meds, Supplements
This step is often where side effects become preventable.
Diabetes medications: If you're on insulin or sulfonylureas, hypoglycemia (low blood sugar) risk can increase when a GLP-1 is added. Your prescriber may need to adjust doses.
Blood pressure medications and diuretics: If your appetite and sodium intake fall, and you're a bit dehydrated, you may feel dizzy or lightheaded. Your clinician may want home blood pressure readings and may adjust meds.
GERD meds: Reflux can worsen when gastric emptying slows. If you're already on acid suppression (like a PPI or H2 blocker), your clinician may discuss timing, diet triggers, and constipation management (because constipation can worsen reflux).
Supplements: Iron, magnesium, fiber, herbal motility aids, and "fat burner" products can all affect GI tolerance. Bring a list or photos of labels. This is not about judgment, it's about preventing avoidable nausea, cramping, or constipation.
Build Your GLP-1 Baseline: Measurements And Symptoms To Track
Labs tell you what's happening internally. A baseline log tells you how you're functioning day to day. When people say, "I don't know if this is the medication or just me," a baseline is what answers that.
Weight, Waist, Blood Pressure, Resting Heart Rate, And Body Composition Options
At minimum, consider tracking:
Weight: Same scale, similar time of day, a few times per week (daily can mess with your head).
Waist circumference: Often tracks visceral fat changes better than weight alone.
Blood pressure and resting heart rate: Especially if you're on antihypertensives, have dizziness, or have a history of palpitations.
Body composition options: If you have access to a DEXA scan, bioimpedance scale, or gym-based assessment, it can help you stay focused on preserving lean mass. Rapid weight loss without enough protein and resistance training can increase lean mass loss, which you want to avoid.
GI Baseline: Constipation, Reflux, Bloating, IBS Triggers, And Hydration
Write down, for at least 1–2 weeks before you start:
How often you have bowel movements, and whether stools are hard, painful, or incomplete.
Reflux frequency (burning, regurgitation, nighttime symptoms).
Bloating patterns: Is it meal-related? Worse with certain foods?
Hydration habits: How much fluid you realistically drink, and whether you're a "forget to drink water" person.
This isn't busywork. Constipation on GLP-1s is common, and if your baseline is already sluggish, you'll want a prevention plan rather than a rescue plan.
Eating Pattern Baseline: Protein, Fiber, FODMAP Sensitivities, And Alcohol
Before GLP-1 therapy changes your appetite, take a quick inventory:
Protein: Roughly how many protein servings do you get daily? Many people overestimate.
Fiber: Are you regularly eating fiber-rich foods, or do you swing between very low fiber and "suddenly lots of fiber," which can worsen bloating?
FODMAP sensitivities: If you know you're sensitive to certain fermentable carbs (common in IBS), note which foods trigger bloating or cramping. A GLP-1 can make your gut less forgiving, so your triggers may feel louder.
Alcohol: Even modest alcohol intake can worsen reflux and nausea, and it can make hydration harder.
If you're someone with IBS or a sensitive stomach, this is also where a low FODMAP approach can be a useful tool, but ideally guided, not random restriction. The goal is tolerability and adequate nutrition, not a shrinking food list.
When To Repeat Labs After Starting (And What Changes Matter)
Once you start, you don't need weekly labs. You do need a schedule that matches your risk.
Typical Timing: 4–12 Weeks, Then Every 3–6 Months (Depending On Risk)
A common approach is:
First recheck around 4–12 weeks after starting or after you've titrated (increased dose) a couple of times, especially if you had borderline kidney function, significant side effects, or diabetes medications that were adjusted.
Then every 3–6 months if you're actively losing weight, adjusting doses, or managing comorbidities like diabetes, fatty liver disease, or hypertension.
Some people can move to less frequent monitoring once they're stable, tolerating the medication, and maintaining weight.
What To Do If Labs Worsen: Dehydration, Electrolytes, Liver Enzymes, Lipids
You don't interpret labs in isolation, you interpret them in context.
If creatinine rises or eGFR drops: One common reason is dehydration from reduced intake, vomiting, diarrhea, or not matching fluids to protein/fiber. Your clinician will look at symptoms, blood pressure, and trends. Don't self-correct with extreme fluid loading or electrolyte products without guidance if you have kidney or heart conditions.
If sodium/potassium are abnormal: This can happen with dehydration, diuretic use, vomiting/diarrhea, or significant dietary shifts. It's fixable, but it should be handled thoughtfully.
If liver enzymes change: Mild fluctuations can occur for many reasons. Sustained elevations or a cholestatic pattern (more Alk Phos/bilirubin involvement) deserves a closer look, especially with right upper abdominal pain.
If lipids change: Many people improve over time, but early shifts can reflect dietary changes (for example, much higher fat intake because "it's all you can tolerate"). This is a moment to adjust strategy, not panic.
Red Flags That Need Urgent Evaluation (Not Just Routine Labs)
Call your clinician urgently or seek urgent evaluation if you develop:
Severe, persistent abdominal pain (especially with vomiting, fever, or pain radiating to the back).
Signs of significant dehydration: inability to keep fluids down, fainting, confusion, very dark urine, or minimal urination.
Jaundice (yellowing of eyes/skin), dark urine with pale stools, or intense right upper abdominal pain, possible biliary obstruction.
Vomiting that doesn't stop, blood in vomit or stool, or severe weakness.
This isn't meant to scare you. It's meant to prevent the common mistake of waiting too long because you assume everything is a "normal GLP-1 side effect." Some things are. Some things aren't.
How To Talk To Your Clinician: A Scripted Checklist You Can Bring
If you've ever left an appointment thinking, "I forgot half my questions," this section is for you. You'll get better care when you make it easy for your clinician to be specific.
Bring your list, and consider using wording like this:
"I'm interested in starting semaglutide/tirzepatide. I'd like baseline labs within the last 6 months so we can monitor safety and side effects. Here are my risk factors and symptoms. What panel do you recommend for me?"
Then go down the checklist.
Questions To Ask About Dosing, Titration, Nausea Prevention, And Constipation Planning
You can ask:
What starting dose do you recommend for me, and why?
How quickly do you plan to titrate, and what symptoms would make you slow down?
What are your first-line strategies for nausea (food timing, meal size, trigger foods), and when should I call you?
What's your constipation prevention plan from day one (hydration targets, fiber strategy, magnesium or other options if appropriate, and when to escalate)?
If I have reflux, what changes do you recommend before increasing the dose?
If you already struggle with constipation or IBS, say it plainly. It changes the plan.
How To Coordinate With Menopause Care, Thyroid Care, Or GI Specialists
Coordination is where care becomes smoother.
Ask:
If I'm in perimenopause/menopause and considering (or already on) hormone therapy, how should we coordinate monitoring and symptom changes?
If my TSH is abnormal or I'm on thyroid medication, do you want to adjust timing, dosing, or monitoring as I lose weight?
If I have IBS, reflux, or a history of gallbladder issues, when would you involve GI, and what symptoms should trigger that referral?
If you're working with multiple clinicians, make sure one person "owns" the big picture. GLP-1 success is rarely about willpower. It's about coordination, dosing, nutrition, and tolerability.
Conclusion
Starting a GLP-1 in 2026 should feel like stepping into a structured plan, not crossing your fingers and hoping you're "one of the lucky ones." Baseline labs won't prevent every side effect. But they dramatically improve your odds of catching problems early, interpreting symptoms correctly, and making smart adjustments without unnecessary stops and starts.
If you use this GLP-1 labs before starting checklist as a conversation tool, core panel, targeted add-ons, medication review, and a simple baseline symptom log, you'll walk into treatment with clarity. And that tends to translate into better adherence, better outcomes, and a calmer experience overall.
Starting GLP-1 therapy raises real questions about nutrition, digestion, and long-term metabolic health. Dr. Onikepe Adegbola, MD PhD, is a physician-scientist specializing in obesity management, hormone optimization, and longevity medicine. She sees patients through Mochi Health (joinmochi.com) and offers evidence-based guidance that goes beyond the prescription. Use code gviqg4 at signup and select her as your provider.
This article is for educational purposes only and is not medical advice. Always consult your healthcare provider before making changes to your treatment plan.
GLP-1 Labs Before Starting Checklist: Frequently Asked Questions
What baseline labs should I get before starting semaglutide or tirzepatide?
Before starting GLP-1 therapy like semaglutide or tirzepatide, a core panel including A1C, fasting glucose, kidney function (CMP/BMP), liver enzymes, fasting lipids, thyroid (TSH), and CBC with ferritin (if needed) is recommended for safety and monitoring.
Why are baseline labs important before starting GLP-1 medications?
Baseline labs screen for safety issues, establish metabolic context, and provide reference points to differentiate medication side effects from pre-existing conditions, enabling better monitoring of kidney, liver, and metabolic health during treatment.
Who needs additional testing before starting GLP-1 therapy?
People with perimenopause/menopause, IBS, gallbladder history, chronic kidney issues, or certain symptoms should consider add-on labs like thyroid hormone levels, pancreatitis markers (lipase/amylase), nutritional vitamins, or inflammation markers for tailored safety.
How often should labs be repeated after starting GLP-1 treatment?
Labs are typically repeated 4 to 12 weeks after starting or dose changes, then every 3 to 6 months depending on individual risk, ongoing weight loss, and comorbidity management to monitor kidney function, electrolytes, liver enzymes, and lipids.
What symptoms or lab changes after starting GLP-1 medications require urgent medical attention?
Seek urgent evaluation for severe persistent abdominal pain, vomiting, fever, jaundice, dehydration signs, or significant enzyme elevations as these may signal gallbladder issues, pancreatitis, or serious complications not typical of normal GLP-1 side effects.
How can I prepare for a discussion with my clinician about starting GLP-1 therapy?
Bring your baseline symptom and measurement log, ask for labs within the last 6 months covering metabolic and safety panels, discuss your personal risks, medication interactions, dosing plans, nausea and constipation prevention, and coordination with specialists as needed.







